{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:58:29Z","timestamp":1773021509549,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006691","name":"Harvard Medical School","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006691","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Planned Parenthood League of Massachusetts and Brigham and Women's Hospital"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.contraception.2011.05.019","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T11:44:40Z","timestamp":1311939880000},"page":"192-197","source":"Crossref","is-referenced-by-count":24,"title":["Can women accurately assess the outcome of medical abortion based on symptoms alone?"],"prefix":"10.1016","volume":"85","author":[{"given":"Andrea V.","family":"Jackson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ila","family":"Dayananda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer M.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garrett","family":"Fitzmaurice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alisa B.","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2011.05.019_bb0005","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/GRF.0b013e3181a2b026","article-title":"Medication abortion","volume":"52","author":"Bartz","year":"2009","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.05.019_bb0010","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.reprotox.2006.03.015","article-title":"Prenatal exposure to misoprostol and congenital anomalies: systematic review and meta analysis","volume":"22","author":"da Silva Dal Pizzol","year":"2006","journal-title":"Reprod Toxicol"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2011.05.019_bb0015","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.1016\/j.ijgo.2007.09.004","article-title":"Misoprostol: pharmacokinetic profiles, effects on the uterus and side-effects","volume":"99","author":"Tang","year":"2007","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.contraception.2011.05.019_bb0020","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/S0002-9378(98)70161-9","article-title":"Mifepristone\u2013misoprostol medical abortion: who will use it and why?","volume":"179","author":"Blinder","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.05.019_bb0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0010-7824(02)00512-7","article-title":"Early abortion services in the United States: a provider survey","volume":"67","author":"Benson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.05.019_bb0030","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1097\/AOG.0b013e31818d8eb4","article-title":"Two distinct oral routes of misoprostol in mifepristone medical abortion: a randomized controlled trial","volume":"112","author":"Winikoff","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2011.05.019_bb0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0010-7824(01)00228-1","article-title":"Mifepristone followed on the same day by vaginal misoprostol for early abortion","volume":"64","author":"Pymar","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.05.019_bb0040","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.contraception.2004.04.005","article-title":"Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion","volume":"70","author":"Rossi","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.05.019_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.contraception.2009.08.008","article-title":"Feasibility of telephone follow-up after medical abortion","volume":"81","author":"Perriera","year":"2010","journal-title":"Contraception"},{"issue":"2 Pt 1","key":"10.1016\/j.contraception.2011.05.019_bb0050","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/AOG.0b013e3181c996f3","article-title":"Alternatives to a routine follow-up visit for early medical abortion","volume":"115","author":"Clark","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"Suppl 2","key":"10.1016\/j.contraception.2011.05.019_bb0055","first-page":"85","article-title":"Termination of early pregnancy (up to 63 days of amenorrhea) with mifepristone and increasing doses of misoprostol","volume":"40","author":"Aubney","year":"1995","journal-title":"Int J Fertil Menopausal Stud"},{"key":"10.1016\/j.contraception.2011.05.019_bb0060","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1056\/NEJM199804303381801","article-title":"Early pregnancy termination with mifepristone and misoprostol in the United States","volume":"338","author":"Spitz","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2011.05.019_bb0065","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1471-0528.2000.tb13273.x","article-title":"Comparison of two doses of mifepristone in combination with misoprostol for early medical abortion: a randomized trial","volume":"107","author":"World Health Organization Task Force on post-ovulatory methods of fertility regulation","year":"2000","journal-title":"BJOG"},{"key":"10.1016\/j.contraception.2011.05.019_bb0070","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0010-7824(01)00200-1","article-title":"Mifepristone and misoprostol for early abortion when no gestational sac is present","volume":"63","author":"Schaff","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2011.05.019_bb0075","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0301-2115(03)00012-5","article-title":"Verifying the effectiveness of medical abortion; ultrasound vs. hCG testing","volume":"109","author":"Fiala","year":"2003","journal-title":"Eur J Obstet Gynecol Reprod Biol"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411002551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782411002551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T02:59:08Z","timestamp":1543633148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782411002551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0010782411002551"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2011.05.019","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}